
Recent News Patent Expirations Through 2016 Predicted to Lower Brand Spending by $127 Billion The U.S. share of global drug spending is expected to decline from 41 percent in 2006 to 31 percent by 2016, primarily due to patent expiries and slower brand growth. In the U.S. and led by Lipitor ...	Recent News Sanofi plans to reshape via $20 billion asset swap with Boehringer ... Sanofi and Boehringer Ingelheim are in exclusive talks over a $20 billion swap of the French pharmaceuticals company's animal health business for the family-owned German group's consumer health operation ...
Recent News Sun Pharma Announces FDA Approval for Generic Gleevec Mumbai, December 04, 2015: Sun Pharmaceutical Industries Ltd. Today announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Gleevec, Imatinib Mesylate tablets 100mg and 400mg ...	Recent News Big pharma is under threat from a whole new kind of generic drug For years, drug makers have feared an onslaught of competition from “biosimilars,” the generic version of drugs that are made by living organisms ...